{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T09:33:27Z","timestamp":1776504807770,"version":"3.51.2"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4968,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2002,5]]},"DOI":"10.1046\/j.1523-1755.2002.00332.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T09:48:02Z","timestamp":1047462482000},"page":"1635-1645","source":"Crossref","is-referenced-by-count":82,"title":["Effect of combining ACE inhibitor and statin in severe experimental nephropathy"],"prefix":"10.1016","volume":"61","author":[{"given":"Carla","family":"Zoja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Corna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Rottoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Zanchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Tomasoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0010","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00041552-199911000-00001","article-title":"Nephropathic nature of proteinuria","volume":"8","author":"Remuzzi","year":"1999","journal-title":"Curr Opin Nephrol Hyperten"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0015","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1046\/j.1523-1755.1998.00905.x","article-title":"Protein overload stimulates RANTES production by proximal tubular cells depending on NF-\u03baB activation","volume":"53","author":"Zoja","year":"1998","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0020","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1681\/ASN.V1061204","article-title":"Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor \u03baB in proximal tubule cells","volume":"10","author":"Wang","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0025","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1053\/ajkd.2000.19838","article-title":"Protein traffic activates NF-\u03baB gene signaling and promotes MCP-1-dependent interstitial inflammation","volume":"36","author":"Donadelli","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00041552-200105000-00003","article-title":"Tubulointerstitial renal disease","volume":"10","author":"Harris","year":"2001","journal-title":"Curr Opin Nephrol Hyperten"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0035","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM199811123392007","article-title":"Pathophysiology of progressive nephropathies","volume":"339","author":"Remuzzi","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0040","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1172\/JCI112528","article-title":"Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat","volume":"77","author":"Anderson","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0045","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1172\/JCI112521","article-title":"Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension","volume":"77","author":"Zatz","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0050","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1681\/ASN.V104804","article-title":"Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein- and complement-dependent interstitial inflammation in experimental renal disease","volume":"10","author":"Abbate","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0055","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0272-6386(97)90038-X","article-title":"The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: Evidence based on comparative studies with a receptor antagonist","volume":"29","author":"Zoja","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0060","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/ki.1994.349","article-title":"Lipids and the kidney","volume":"46","author":"Keane","year":"1994","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0065","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/ki.1990.62","article-title":"Renal injury of diet-induced hypercholesterolemia in rats","volume":"37","author":"Kasiske","year":"1990","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/01.RES.62.2.367","article-title":"Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5\/6 nephrectomy model of chronic renal failure","volume":"62","author":"Kasiske","year":"1988","journal-title":"Circ Res"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0272-6386(12)70172-5","article-title":"Lovastatin retards the progression of established glomerular disease in obese Zucker rats","volume":"22","author":"O'Donnell","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0080","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1681\/ASN.V11180","article-title":"Lovastatin inhibits transforming growth factor-\u03b21 expression in diabetic rat glomeruli and cultured rat mesangial cells","volume":"11","author":"Kim","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0272-6386(12)80587-7","article-title":"Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome","volume":"15","author":"Harris","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/ajkd.1998.v31.pm9428473","article-title":"Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats","volume":"31","author":"Park","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0095","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1681\/ASN.V9112027","article-title":"Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis","volume":"9","author":"Yoshimura","year":"1998","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 71","key":"10.1046\/j.1523-1755.2002.00332.x_bb0100","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1046\/j.1523-1755.1999.07101.x","article-title":"Recent advances in statins and the kidney","volume":"56","author":"Oda","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1172\/JCI116204","article-title":"Lovastatin inhibits proliferation of rat mesangial cells","volume":"91","author":"O'Donnell","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0110","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ki.1997.423","article-title":"Lovastatin-induced inhibition of renal epithelial tubular cell proliferation involves a p21ras activated, AP-1-dependent pathway","volume":"52","author":"Vrtovsnik","year":"1997","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0115","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ki.1995.304","article-title":"Human mesangial cell production of monocyte chemoattractant protein-1: Modulation by lovastatin","volume":"48","author":"Kim","year":"1995","journal-title":"Kidney Int"},{"issue":"Suppl 77","key":"10.1046\/j.1523-1755.2002.00332.x_bb0120","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1046\/j.1523-1755.2000.07714.x","article-title":"Effect of lovastatin on small GTP binding proteins and on TGF-\u03b21 and fibronectin expression","volume":"58","author":"Kim","year":"2000","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0125","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(99)08347-6","article-title":"Prenylation inhibitors in renal disease","volume":"355","author":"Khwaja","year":"2000","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1523-1755.2001.059002415.x","article-title":"Transcription factor-\u03baB (NF-\u03baB) and renal disease","volume":"59","author":"Guijarro","year":"2001","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0135","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.1998.00011.x","article-title":"Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy","volume":"54","author":"Benigni","year":"1998","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0140","first-page":"957","article-title":"Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats","volume":"78","author":"Pfeffer","year":"1971","journal-title":"J Lab Clin Med"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0003-2697(81)90321-3","article-title":"Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein","volume":"116","author":"Read","year":"1981","journal-title":"Anal Biochem"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0150","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0021-9258(19)51334-5","article-title":"The colorimetric determination of creatinine of the Jaff\u00e9 reaction","volume":"158","author":"Bonsnes","year":"1945","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0155","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/ajkd.1998.v31.pm9506682","article-title":"Pharmacologic control of Angiotensin II ameliorates renal disease while reducing renal TGF-\u03b2 in experimental mesangioproliferative glomerulonephritis","volume":"31","author":"Zoja","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0160","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1182\/blood.V69.5.1409.1409","article-title":"Expression of the M-CSF (CSF-1) gene by human monocytes","volume":"69","author":"Rambaldi","year":"1987","journal-title":"Blood"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0165","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","author":"The GISEN Group","year":"1997","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0170","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ki.1987.278","article-title":"Converting enzyme inhibition and progressive glomerulosclerosis in the rat","volume":"32","author":"Beukers","year":"1987","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0175","first-page":"F35","article-title":"Glomerular adaptations with normal aging and with long-term converting enzyme inhibition in rats","volume":"267","author":"Anderson","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0180","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ki.1989.267","article-title":"Effect of converting enzyme inhibition on the course of adriamycin-induced nephropathy","volume":"36","author":"Scholey","year":"1989","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.jhh.1000732","article-title":"Long-term effects of ramipril and nitrendipine on albuminuria in hypertensive patients with type II diabetes and impaired renal function","volume":"13","author":"Fogari","year":"1999","journal-title":"J Hum Hypertens"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0190","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1046\/j.1523-1755.1999.055003984.x","article-title":"Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade","volume":"55","author":"Ruggenenti","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0195","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0140-6736(00)04728-0","article-title":"Progression, remission, regression of chronic renal diseases","volume":"357","author":"Ruggenenti","year":"2001","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0200","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1681\/ASN.V1071542","article-title":"Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals","volume":"10","author":"Remuzzi","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl","key":"10.1046\/j.1523-1755.2002.00332.x_bb0205","first-page":"S234","article-title":"Coinhibition of immune and renin-angiotensin systems reduces the pace of glomerulosclerosis in the rat remnant kidney","volume":"10","author":"Hamar","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0210","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1046\/j.1523-1755.2000.00093.x","article-title":"A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats","volume":"57","author":"Wang","year":"2000","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0215","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF00856524","article-title":"The combination of lovastatin and enalapril in a model of progressive renal disease","volume":"4","author":"Brouhard","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0220","first-page":"1338","article-title":"Effects of delayed treatment with enalapril and\/or lovastatin on the progression of glomerulosclerosis in 5\/6 nephrectomized rats","volume":"8","author":"Lee","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00041552-200103000-00007","article-title":"Dyslipidemia and renal disease: Pathogenesis and clinical consequences","volume":"10","author":"Wanner","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0230","first-page":"1501","article-title":"Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive Heymann nephritis","volume":"79","author":"Remuzzi","year":"1999","journal-title":"Lab Invest"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0235","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1681\/ASN.V125941","article-title":"Blocking angiotensin II synthesis\/activity preserves glomerular nephrin in rats with severe nephrosis","volume":"12","author":"Benigni","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0240","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0002-9440(10)63021-0","article-title":"ACE inhibition prevents glomerular-tubule disconnection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonist","volume":"159","author":"Benigni","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0245","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1046\/j.1523-1755.2000.00304.x","article-title":"Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects","volume":"58","author":"Park","year":"2000","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00332.x_bb0250","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/ndt\/11.6.990","article-title":"Lovastatin inhibits lipopolysaccharide-induced NF-\u03baB activation in human mesangial cells","volume":"11","author":"Guijarro","year":"1996","journal-title":"Nephrol Dial Transplant"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815484005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815484005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T04:22:07Z","timestamp":1621138927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815484005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["S0085253815484005"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00332.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}